Latest period
$40.87B
YoY change
+7.4%
5Y CAGR
+18.8%
Peak year (2025)
$40.56B
Latest annual
$40.56B
Total Assets history chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
Latest: $40.56B
Total Assets growth chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
Latest: +7.4%
Total Assets history table for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
| 2025 | $40.56B | +7.4% | +$2.80B | ||
| 2024 | $37.76B | +14.1% | +$4.68B | ||
| 2023 | $33.08B | +13.2% | +$3.87B | ||
| 2022 | $29.21B | +14.9% | +$3.78B | ||
| 2021 | $25.43B | +48.2% | +$8.27B | ||
| 2020 | $17.16B | +15.9% | +$2.36B | ||
| 2019 | $14.81B | +26.2% | +$3.07B | ||
| 2018 | $11.73B | +33.9% | +$2.97B | ||
| 2017 | $8.76B | +25.7% | +$1.79B | ||
| 2016 | $6.97B | +24.3% | +$1.36B | ||
| 2015 | $5.61B | +44.9% | +$1.74B | ||
| 2014 | $3.87B | +31.2% | +$920.81M | ||
| 2013 | $2.95B | +41.8% | +$870.52M | ||
| 2012 | $2.08B | +57.2% | +$756.91M | ||
| 2011 | $1.32B | +21.5% | +$234.15M | ||
| 2010 | $1.09B | +47.0% | +$348.23M | ||
| 2009 | $741.20M | +10.6% | +$71.16M | ||
| 2008 | $670.04M | -28.4% | −$266.22M | ||
| 2007 | $936.26M | +60.0% | +$351.17M | ||
| 2006 | $585.09M | +38.2% | +$161.59M | ||
| 2005 | $423.50M | -10.5% | −$49.61M | ||
| 2004 | $473.11M | -1.3% | −$6.45M | ||
| 2003 | $479.56M | +22.5% | +$87.98M | ||
| 2002 | $391.57M | -21.0% | −$103.82M | ||
| 2001 | $495.40M | +137.9% | +$287.12M | ||
| 2000 | $208.27M | +52.0% | +$71.27M | ||
| 1999 | $137.00M | -12.7% | −$19.90M | ||
| 1998 | $156.90M | -6.8% | −$11.50M | ||
| 1997 | $168.40M | +22.4% | +$30.80M | ||
| 1996 | $137.60M | +46.7% | +$43.80M | ||
| 1995 | $93.80M | -0.4% | −$400.00K | ||
| 1994 | $94.20M | -19.9% | −$23.40M | ||
| 1993 | $117.60M | +20.1% | +$19.70M | ||
| 1992 | $97.90M | -14.1% | −$16.10M | ||
| 1991 | $114.00M | +348.8% | +$88.60M | ||
| 1990 | $25.40M | — | — |
- 2025$40.56B+7.4%
- 2024$37.76B+14.1%
- 2023$33.08B+13.2%
- 2022$29.21B+14.9%
- 2021$25.43B+48.2%
- 2020$17.16B+15.9%
- 2019$14.81B+26.2%
- 2018$11.73B+33.9%
- 2017$8.76B+25.7%
- 2016$6.97B+24.3%
- 2015$5.61B+44.9%
- 2014$3.87B+31.2%
- 2013$2.95B+41.8%
- 2012$2.08B+57.2%
- 2011$1.32B+21.5%
- 2010$1.09B+47.0%
- 2009$741.20M+10.6%
- 2008$670.04M-28.4%
- 2007$936.26M+60.0%
- 2006$585.09M+38.2%
- 2005$423.50M-10.5%
- 2004$473.11M-1.3%
- 2003$479.56M+22.5%
- 2002$391.57M-21.0%
- 2001$495.40M+137.9%
- 2000$208.27M+52.0%
- 1999$137.00M-12.7%
- 1998$156.90M-6.8%
- 1997$168.40M+22.4%
- 1996$137.60M+46.7%
- 1995$93.80M-0.4%
- 1994$94.20M-19.9%
- 1993$117.60M+20.1%
- 1992$97.90M-14.1%
- 1991$114.00M+348.8%
- 1990$25.40M—
Total Assets values are taken from Regeneron Pharmaceuticals's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Regeneron Pharmaceuticals (REGN)
According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported total assets is $40.87B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total assets for Regeneron Pharmaceuticals (REGN) came in at $40.56B – grew 7.4% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Regeneron Pharmaceuticals total assets compounded at +18.8% per year, sustaining 17 straight years of year-over-year growth.
Across the available history, total assets reached its high of $40.56B in 2025 and its low of $25.40M in 1990.
Regeneron Pharmaceuticals Total Assets by Year
Regeneron Pharmaceuticals Total Assets 2025: $40.56B
Regeneron Pharmaceuticals posted total assets of $40.56B in 2025, grew 7.4% from 2024. This figure represents the highest annual value in the available history.
Regeneron Pharmaceuticals Total Assets 2024: $37.76B
In 2024, Regeneron Pharmaceuticals reported total assets of $37.76B, grew 14.1% from 2023.
Regeneron Pharmaceuticals Total Assets 2023: $33.08B
Regeneron Pharmaceuticals total assets in 2023 was $33.08B, grew 13.2% from 2022.
Regeneron Pharmaceuticals Total Assets 2022: $29.21B
2022's total assets for Regeneron Pharmaceuticals came in at $29.21B, grew 14.9% from 2021.
Regeneron Pharmaceuticals Total Assets 2021: $25.43B
Regeneron Pharmaceuticals total assets in 2021 was $25.43B.
See more financial history for Regeneron Pharmaceuticals (REGN).
Sector peers by Total Assets
Healthcare peers of Regeneron Pharmaceuticals (REGN), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $90.59B
- $85.37B
Frequently asked questions
Regeneron Pharmaceuticals (REGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation